WebView the real-time CTXR price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. ... CTXR Earnings-$0.06-$0.04-$0.02. $0.00. Q4 FY21. Q1 FY22. Q2 FY22. Q3 FY22. WebJul 14, 2024 · CTXR Citius Pharmaceuticals $1.28 / -0.015 (-1.16%) 12/01/22 ... Earnings. Fortress Biotech reports Q3 EPS ... Up-to-date information on important industry events Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
Citius Pharma Stock (NASDAQ:CTXR), Earnings Estimates, EPS, …
WebApr 2, 2024 · NASDAQ CTXR opened at $1.17 on Friday. The firm has a market cap of $171.12 million, a P/E ratio of -6.50 and a beta of 1.40. The stock’s 50-day moving average is $1.18 and its 200-day moving ... WebCTXR Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. flip awo
Citius Pharmaceuticals (CTXR) Stock Forecast & Price Target - TipRanks
WebMarket Cap. $169.66 M. Shares Outstanding. 146.26 M. Public Float. 133.95 M. Yield. CTXR is not currently paying a regular dividend. Latest Dividend. WebApr 10, 2024 · About CTXR. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products … WebAug 8, 2024 · It turns out an average annual growth rate of 75% is expected, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts... greater tilton family resource center nh